Sampling procedures used for acceptance testing of in vitro diagnostic medical devices - Statistical aspects

This European Standard specifies sampling procedure requirements for acceptance testing of finished in vitro diagnostic medical devices, which require EU verification by a notified body.
Two different provisions are addressed:
a) verification by testing attributes and/or variables on a statistical basis;
b) verification by testing a homogeneous batch which has been defined by appropriate means of process validation and in-process control.
This standard specifies requirements and criteria for testing procedures to establish and verify the homogeneity of processes and products. This standard is also applicable for drawing up sampling plans for finished products according to the requirements laid down for manufacturers' product certification and production quality systems.

Probenahmeverfahren für die Annahmeprüfung von In-vitro-Diagnostika - Statistische Aspekte

Diese Europäische Norm legt Anforderungen an Probenahmeverfahren für die Annahmeprüfung fertiger In-vitro-Diagnostika fest, die einer EG-Prüfung durch eine benannte Stelle bedürfen.
Dabei werden zwei verschiedene Bestimmungen berücksichtigt:
a) Prüfung durch statistische Kontrolle von Attributen und/oder Variablen;
b) Prüfung und Kontrolle einer homogenen Charge, die durch geeignete Prozessvalidierung und prozessinterne Kontrollmaßnahmen festgelegt ist.
Diese Norm legt Anforderungen und Kriterien für die Prüfungen fest, durch welche die Homogenität von Prozessen und Produkten nachgewiesen und kontrolliert wird. Diese Norm gilt auch für die Erstellung von Stichprobenplänen für Fertigprodukte nach den Bestimmungen für Produktzertifizierungs-programme und Qualitätsmanagementsysteme des Herstellers.

Procédures d'échantillonnage utilisées pour l'acceptation des essais des dispositifs médicaux de diagnostic in vitro - Aspects statistiques

La présente Norme Européenne spécifie des exigences relatives aux procédures d'échantillonnage à appliquer pour les essais pour acceptation des dispositifs médicaux de diagnostic in vitro qui nécessitent une vérification CE par un organisme notifié.
Deux dispositions différentes sont abordées :
a) la vérification par un contrôle par attributs et/ou variables, sur une base statistique ;
b) la vérification par le contrôle d'un lot homogène ayant été défini par une validation des processus et un moyen adapté de contrôle en cours de fabrication.
La présente norme fixe des exigences et des critères relatifs aux procédures d'essai qui visent à établir et vérifier l'homogénéité des processus et des produits. Elle est également applicable à l'élaboration de plans d'échantillonnage destinés aux produits finis, conformes aux exigences fixées dans les systèmes de qualité de la production et de certification des produits, appliqués par les fabricants.

Postopki vzorčenja, ki se uporabljajo pri preskusih sprejema in vitro diagnostičnih pripomočkov – Statistični vidiki

General Information

Status
Published
Publication Date
31-Aug-2003
Technical Committee
VAZ - Healthcare
Current Stage
6060 - National Implementation/Publication (Adopted Project)
Start Date
01-Sep-2003
Due Date
01-Sep-2003
Completion Date
01-Sep-2003

Overview

EN 13975:2003 - Sampling procedures used for acceptance testing of in vitro diagnostic medical devices - provides requirements and guidance for designing and applying sampling procedures for acceptance testing of finished in vitro diagnostic (IVD) medical devices requiring EC verification by a notified body. The standard addresses two primary routes for verification: statistical verification (inspection by attributes and/or variables) and verification of homogeneous batches established by process validation and in‑process control. EN 13975:2003 supports Annex VI of Directive 98/79/EC and is intended for use within manufacturers’ production quality systems and by notified bodies performing EC verification.

Key topics and requirements

  • Scope and applicability: Sampling procedures for acceptance testing of finished IVDs, and criteria for establishing product/process homogeneity.
  • Two verification approaches:
    • Statistical verification using sampling plans by attributes or variables.
    • Verification based on demonstrated homogeneity through process validation and in‑process control.
  • Standards referenced: Sampling plans should be taken from established standards such as ISO 2859 (attributes) and ISO 3951 (variables). EN 13975 requires manufacturers to specify probabilities of acceptance and acceptable quality (AQL or LQ).
  • Sampling plan documentation: If deviating from referenced standards, manufacturers must document the statistical basis, operating characteristic (OC) curve/table, sampling strategy, sample sizes and acceptance criteria.
  • Validation and process control: Emphasis on process validation, monitoring, and verification that manufacturing yields homogeneous batches; requirements to justify sampling plan reductions based on historical data.
  • Statistical process control (SPC): Use of SPC for variables/attributes (small subgroup sizes commonly 2–5) to demonstrate process stability and capability.
  • 100% verification and other controls: Guidance on 100% verification and other process-control methods where appropriate; describes when final testing of finished devices can be reduced or omitted.

Practical applications and users

Who uses EN 13975:2003:

  • IVD manufacturers - to design sampling plans, validate processes, and demonstrate batch homogeneity for product certification and production quality systems.
  • Notified bodies - for EC verification and assessment of manufacturers’ sampling strategies.
  • Quality assurance, regulatory affairs, and production engineers - for establishing operational quality control plans integrating SPC, process validation and final testing. Practical uses:
  • Developing compliant sampling plans for lot acceptance.
  • Justifying reduced or targeted final testing where robust in‑process control exists.
  • Documenting statistical rationale when non‑standard sampling plans are proposed.

Related standards

  • ISO 2859‑1/2/3 - Sampling procedures for inspection by attributes (AQL / LQ / skip‑lot).
  • ISO 3951 - Sampling procedures and charts for inspection by variables.
  • EN ISO 9000 series - Quality management and validation/verification terminology.
  • Directive 98/79/EC, Annex VI - EC verification requirements for IVDs.

Keywords: EN 13975:2003, sampling procedures, acceptance testing, in vitro diagnostic medical devices, statistical verification, process validation, notified body, ISO 2859, ISO 3951, AQL, batch homogeneity.

Frequently Asked Questions

SIST EN 13975:2003 is a standard published by the Slovenian Institute for Standardization (SIST). Its full title is "Sampling procedures used for acceptance testing of in vitro diagnostic medical devices - Statistical aspects". This standard covers: This European Standard specifies sampling procedure requirements for acceptance testing of finished in vitro diagnostic medical devices, which require EU verification by a notified body. Two different provisions are addressed: a) verification by testing attributes and/or variables on a statistical basis; b) verification by testing a homogeneous batch which has been defined by appropriate means of process validation and in-process control. This standard specifies requirements and criteria for testing procedures to establish and verify the homogeneity of processes and products. This standard is also applicable for drawing up sampling plans for finished products according to the requirements laid down for manufacturers' product certification and production quality systems.

This European Standard specifies sampling procedure requirements for acceptance testing of finished in vitro diagnostic medical devices, which require EU verification by a notified body. Two different provisions are addressed: a) verification by testing attributes and/or variables on a statistical basis; b) verification by testing a homogeneous batch which has been defined by appropriate means of process validation and in-process control. This standard specifies requirements and criteria for testing procedures to establish and verify the homogeneity of processes and products. This standard is also applicable for drawing up sampling plans for finished products according to the requirements laid down for manufacturers' product certification and production quality systems.

SIST EN 13975:2003 is classified under the following ICS (International Classification for Standards) categories: 11.100.10 - In vitro diagnostic test systems. The ICS classification helps identify the subject area and facilitates finding related standards.

SIST EN 13975:2003 is associated with the following European legislation: EU Directives/Regulations: 98/79/EC; Standardization Mandates: M/252. When a standard is cited in the Official Journal of the European Union, products manufactured in conformity with it benefit from a presumption of conformity with the essential requirements of the corresponding EU directive or regulation.

You can purchase SIST EN 13975:2003 directly from iTeh Standards. The document is available in PDF format and is delivered instantly after payment. Add the standard to your cart and complete the secure checkout process. iTeh Standards is an authorized distributor of SIST standards.

Standards Content (Sample)


2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.Sampling procedures used for acceptance testing of in vitro diagnostic medical devices - Statistical aspectsProcédures d'échantillonnage utilisées pour l'acceptation des essais des dispositifs médicaux de diagnostic in vitro - Aspects statistiquesProbenahmeverfahren für die Annahmeprüfung von In-vitro-Diagnostika - Statistische AspekteTa slovenski standard je istoveten z:EN 13975:2003SIST EN 13975:2003en11.100.10In vitro diagnostic test systemsICS:SLOVENSKI
STANDARDSIST EN 13975:200301-september-2003

EUROPEAN STANDARDNORME EUROPÉENNEEUROPÄISCHE NORMEN 13975March 2003ICS 11.100English versionSampling procedures used for acceptance testing of in vitrodiagnostic medical devices - Statistical aspectsProcédures d'échantillonnage utilisées pour l'acceptationdes essais des dispositifs médicaux de diagnostic in vitro -Aspects statistiquesProbenahmeverfahren für die Annahmeprüfung von In-vitro-Diagnostika - Statistische AspekteThis European Standard was approved by CEN on 14 November 2002.CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for giving this EuropeanStandard the status of a national standard without any alteration. Up-to-date lists and bibliographical references concerning such nationalstandards may be obtained on application to the Management Centre or to any CEN member.This European Standard exists in three official versions (English, French, German). A version in any other language made by translationunder the responsibility of a CEN member into its own language and notified to the Management Centre has the same status as the officialversions.CEN members are the national standards bodies of Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece,Hungary, Iceland, Ireland, Italy, Luxembourg, Malta, Netherlands, Norway, Portugal, Slovakia, Spain, Sweden, Switzerland and UnitedKingdom.EUROPEAN COMMITTEE FOR STANDARDIZATIONCOMITÉ EUROPÉEN DE NORMALISATIONEUROPÄISCHES KOMITEE FÜR NORMUNGManagement Centre: rue de Stassart, 36
B-1050 Brussels© 2003 CENAll rights of exploitation in any form and by any means reservedworldwide for CEN national Members.Ref. No. EN 13975:2003 E

is measured in a sample of units of product, eithercomponents or finished devices, to establish statistically the acceptability of a batch3.8limiting qualityLQwhen a batch is considered in isolation, a quality level which for the purposes of sampling inspection is limited to alow probability of acceptance[ISO 2859-1:1999]3.9sampleone or more units of product, either components or finished devices, drawn from a batch without regard to thequality of the units3.10sample sizenumber of units of product in the sample3.11sampling planplan that indicates the number of units of product, either components or finished devices, from each batch which isto be drawn for inspection and the associated criteria for determining the acceptability of the batch
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.

Loading comments...

SIST EN 13975:2003 표준은 체외 진단 의료기기의 수용 테스트를 위한 샘플링 절차에 관한 필수 요구사항을 제시하며, 이는 EU 인증을 요구하는 최종 제품에 적용됩니다. 이 표준은 두 가지 주요 조항을 다루고 있습니다: 첫째, 통계적 기반에 의한 속성 및/또는 변수를 테스트하여 검증하는 것; 둘째, 적절한 공정 검증 및 공정 중 통제를 통해 정의된 동질적 배치를 테스트하여 검증하는 것입니다. 이 표준의 강점 중 하나는 공정 및 제품의 동질성을 확립하고 검증하기 위한 테스트 절차에 대한 요구사항 및 기준을 구체적으로 명시하고 있다는 점입니다. 이는 제조업체의 제품 인증과 생산 품질 시스템 요구사항에 따라 최종 제품의 샘플링 계획을 수립하는 데 매우 유용합니다. 결과적으로, SIST EN 13975:2003은 체외 진단 의료기기의 품질 보증 및 인증 절차의 필수적인 요소로 자리잡고 있습니다. 또한, 이 표준은 제조업체가 제품의 일관성을 유지하고, EU의 규제 요구사항을 충족할 수 있도록 돕는 역할을 합니다. 통계적 접근을 채택함으로써, 제품의 테스트 과정에서 신뢰성을 높이고, 시장에서의 경쟁력을 강화할 수 있는 기반을 제공합니다. 전반적으로 SIST EN 13975:2003 표준은 체외 진단 의료기기 업계에서 중요한 참고 자료로 여겨지며, 안전하고 효과적인 진단 솔루션을 제공하는 데 기여합니다.

Die SIST EN 13975:2003 ist ein entscheidendes Dokument, das die Anforderungen an die Probenahmeverfahren für die Akzeptanzprüfung von In-vitro-Diagnosemedizingeräte festlegt. Diese Norm ist besonders relevant für Hersteller, die eine EU-Bestätigung durch eine benannte Stelle benötigen. Der Geltungsbereich der Norm umfasst sowohl die statistische Überprüfung von Attributen und Variablen als auch die Überprüfung eines homogenen Batches, der durch geeignete Mittel der Prozessvalidierung und der In-Prozess-Kontrolle definiert wurde. Ein besonderer Stärke der SIST EN 13975:2003 liegt in ihrer detaillierten Beschreibung der Anforderungen und Kriterien für Prüfverfahren, um die Homogenität von Prozessen und Produkten zu bestätigen. Dadurch wird sichergestellt, dass die In-vitro-Diagnoseprodukte sowohl den geforderten Qualitätsstandards entsprechen als auch zuverlässig in der Anwendung sind. Diese Norm unterstützt Hersteller dabei, fundierte Sampling-Pläne für fertige Produkte aufzustellen, welche den Anforderungen an die Produktzertifizierung und die Produktionsqualitätssysteme gerecht werden. Die Relevanz dieser Norm kann nicht hoch genug eingeschätzt werden, da sie eine strukturierte Herangehensweise an die Qualitätskontrolle von In-vitro-Diagnosemedizingeräten bietet. Sie ermöglicht eine systematische und statistisch fundierte Überprüfung der Produktionsprozesse und trägt damit zur Erhöhung der Sicherheit und Effektivität der Produkte bei. Die Möglichkeit, durch verschiedene Prüfmethoden die Homogenität zu verifizieren, ist ein wesentlicher Bestandteil für die Zulassung und Marktgängigkeit der Produkte innerhalb der EU. Zusammenfassend lässt sich sagen, dass die SIST EN 13975:2003 eine essentielle Grundlage für die gewährleistete Prüfqualität von In-vitro-Diagnosemedizingeräten darstellt und sich somit als unverzichtbar für die Hersteller in diesem Bereich erweist.

The SIST EN 13975:2003 standard addresses essential requirements for sampling procedures used in the acceptance testing of in vitro diagnostic medical devices, notably emphasizing statistical aspects. Its scope includes two key provisions: the verification by testing attributes and/or variables and the verification by testing a homogeneous batch, emphasizing the significance of process validation and in-process control. One strength of this standard lies in its detailed framework for establishing rigorous sampling procedures, which is crucial for manufacturers to ensure their products meet EU verification standards before being brought to market. The emphasis on statistical verification supports credible and replicable testing outcomes that enhance product reliability. Moreover, the document outlines clear requirements for assessing the homogeneity of both processes and products. This aspect is particularly relevant for manufacturers aiming to uphold high quality within their production quality systems and ensure compliance with certification expectations. By providing methodologies for drawing up sampling plans tailored to the stringent requirements of in vitro diagnostic medical devices, SIST EN 13975:2003 proves to be an indispensable asset for entities involved in the development and testing of such medical technologies. Its focus on standardization not only contributes to improving product quality but also aligns with the broader regulatory framework within the EU, ensuring that manufacturers can effectively navigate compliance while maintaining industry standards.

SIST EN 13975:2003は、in vitro診断医療機器の受入試験におけるサンプリング手続きのための統計的要素を定めた重要な欧州規格です。この規格は、EU認証が必要な完成したin vitro診断医療機器に対して適用されます。 本規格の範囲には、2つの主要な規定が含まれています。まず、統計的基準に基づく特性および/または変数のテストによる検証が挙げられます。これは、医療機器の信頼性を確保するために非常に重要です。次に、適切なプロセスバリデーションおよび工程管理によって定義された均質なバッチをテストすることによる検証が含まれます。このように、SIST EN 13975:2003は、試験手続きの要件や基準を明確に示し、プロセスや製品の均質性を確立および検証するための基盤を提供します。 特に、本規格は製造業者の製品認証や生産品質システムに基づき、完成品のサンプリングプランの作成にも応用可能です。これにより、規制当局や市場に対して透明性のあるデータ提供が可能になり、医療機器の品質向上に寄与します。このように、SIST EN 13975:2003 は、in vitro診断医療機器の受入試験に関するサンプリング手続きの国際的な整合性を促進するための強力なフレームワークを提供しています。

La norme SIST EN 13975:2003 offre un cadre essentiel pour la mise en œuvre de procédures d'échantillonnage lors des tests d'acceptation des dispositifs médicaux de diagnostic in vitro. En précisant des exigences de procédures d'échantillonnage pour les dispositifs terminés, elle garantit que ces produits, nécessitant une vérification par un organisme notifié de l'UE, sont conformes aux standards requis. L'une des forces notables de cette norme réside dans sa structure qui aborde deux modalités distinctes de vérification. D'une part, elle permet la vérification par des tests d'attributs et/ou de variables sur une base statistique, ce qui assure une approche rigoureuse et fondée sur des données probantes pour évaluer la qualité des dispositifs médicaux. D'autre part, la norme offre également des directives pour la vérification d'un lot homogène, défini par des moyens appropriés de validation des processus et de contrôle en cours de processus. Cela s'avère crucial pour les fabricants cherchant à établir la fiabilité et la validité de leurs produits. De plus, la norme SIST EN 13975:2003 intègre des critères clairs pour les procédures de test visant à établir et vérifier l'homogénéité des processus et des produits. Cela contribue non seulement à assurer la conformité des dispositifs médicaux, mais aussi à renforcer la confiance des utilisateurs finaux dans leur sécurité et leur efficacité. En outre, cette norme est particulièrement pertinente pour l'élaboration de plans d'échantillonnage pour les produits finis, en tenant compte des exigences définies pour la certification des produits des fabricants et les systèmes de qualité de production. Cela permet aux entreprises de s'assurer qu'elles respectent les normes de qualité exigées par le marché européen, tout en facilitant une gestion rigoureuse de la qualité dans l'ensemble du cycle de vie des dispositifs médicaux. Dans l'ensemble, la norme SIST EN 13975:2003 se positionne comme un outil indispensable pour les fabricants de dispositifs médicaux de diagnostic in vitro, leur permettant de naviguer efficacement dans les exigences réglementaires et de garantir un niveau élevé de qualité et de sécurité pour leurs produits.